A Phase 1 Study of ASP3082 in Participants With Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies With KRAS G12D Mutation

158123082-CL-0101-NCT05382559OpenA Phase 1 Study of ASP3082 in Participants With Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies With KRAS G12D Mutation3082-CL-0101NCT05382559IndustrialAdultTreatmentIOtherNoel, MarcusGeorgetown University Medical Center : Shannon Raue; Lombardi Comprehensive Cancer Center : Shannon RauePhase IOncology GroupLombardi Comprehensive Cancer Center (LCCC); Oncology PFS16186Shannon RaueShannon Rauesr1657@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>